| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/18/2005 | CN1615835A 硫普罗宁软胶囊 Tiopronin soft capsules |
| 05/18/2005 | CN1615828A Garlicin injection emulsion and its preparing method |
| 05/18/2005 | CN1202252C Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
| 05/18/2005 | CN1202096C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1201809C Preparation of Chinese herbal medicine for removal of urinary calculus |
| 05/18/2005 | CN1201808C Chinese medicinal pill preparation for treating chronic colonitis |
| 05/18/2005 | CN1201797C Medicine for treating gastritis and preparation process thereof |
| 05/18/2005 | CN1201794C Children's health-care tonic liquor for promoting function of digestion and assimilation |
| 05/18/2005 | CN1201789C Ascites pill |
| 05/18/2005 | CN1201788C Medical composition possessing function of refreshing oneself, senium-resistant, reinforcing body fluid and nourishing the blood, nourishing liver and preparing method |
| 05/18/2005 | CN1201786C Traditional Chinese medicine composition for curing child's dyspepsia and cough and its preparing method |
| 05/18/2005 | CN1201784C Chinese medicine oral medicine for treating stomach-pain |
| 05/18/2005 | CN1201772C Chinese medicine for treating chronic atrophic gastritis |
| 05/18/2005 | CN1201732C Oral pharmaceutical forms of administration with a delayed action |
| 05/18/2005 | CN1201731C Medicine preparation and its use and the use of high grade primary alcohol mixture |
| 05/18/2005 | CN1201681C Composite solid sprulina healthy beverage and its preparation |
| 05/17/2005 | US6894168 Carbamoyl tetrahydropyridine derivatives |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |
| 05/17/2005 | US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives |
| 05/17/2005 | US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
| 05/17/2005 | US6894038 Administering an estriol 3,17-dipropionate or an estriol 3,17-dihexanoate, for treating multiple sclerosis |
| 05/17/2005 | US6894036 4-dedimethylaminotetracycline derivatives |
| 05/17/2005 | US6894033 Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
| 05/17/2005 | US6893665 Tetracycline derivatives that are not removed from the gastro-intestinal tract via absorption, therefore having minimal systemic exposure and accompanying side effects in cancer therapy |
| 05/17/2005 | US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 05/17/2005 | CA2335492C Pyrrolo[2,3-d]pyrimidine compounds |
| 05/12/2005 | WO2005042727A2 Methods of organ regeneration |
| 05/12/2005 | WO2005032571A3 Method for the production of a medicinal tincture from higher mushrooms, medicinal tincture and use thereof |
| 05/12/2005 | WO2005007699A3 Human antibody molecules for il-13 |
| 05/12/2005 | WO2004082715A8 Concomitant drug as therapeutic agent for inflammatory bowel disease |
| 05/12/2005 | WO2004071391A3 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 05/12/2005 | WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101664 Anionically coupling an acyl imidazoyl carbamate with a primary amide or carbamate; N-alkylation; inosine-5*-monophosphate dehydrogenase inhibitors |
| 05/12/2005 | US20050101649 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | US20050101635 Delivering to an external portion of the body passageway of a patient in need of a therapeutically effective amount of an antihistamine or decongestant to treat inflammatory diseases |
| 05/12/2005 | US20050101632 Treating inflammation of the skin or mucous membrane by topical administration of an anti-inflammatory amount of dimethicone in the absence of any other anti-inflammatory agent |
| 05/12/2005 | US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
| 05/12/2005 | US20050101611 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor |
| 05/12/2005 | US20050101600 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress |
| 05/12/2005 | US20050101591 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 05/12/2005 | US20050101567 Using a sulfonamide containing compound |
| 05/12/2005 | US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders |
| 05/12/2005 | US20050101557 Immunostimulatory nucleic acid molecules |
| 05/12/2005 | US20050101554 Methods for treating and preventing infectious disease |
| 05/12/2005 | US20050101546 Increased solubility flavanolignan preparations |
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050101527 Method for treating the central nervous system by administration of igf structural analogs |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors |
| 05/12/2005 | US20050100617 Method for improving age-related physiological deficits and increasing longevity |
| 05/12/2005 | US20050100597 salt of diclofenac with tromethamine; gingivitis, glossitis, stomatitis, aphthae, paradentosis, paradentitis, laryngitis, pharyngitis, mucositis of the oral cavity caused by radiotherapy and chemotherapy |
| 05/12/2005 | US20050100540 Platelet-activating factor acetylhydrolase |
| 05/12/2005 | US20050100530 Medicinal composition |
| 05/12/2005 | CA2544325A1 Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| 05/12/2005 | CA2544125A1 Use of ephrins and related molecules to regulate cellular proliferation |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543649A1 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 05/11/2005 | EP1529054A2 Therapeutic protein and treatments |
| 05/11/2005 | EP1529046A1 Substituted benzimidazole compounds |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1528921A2 Methods for treatment and prevention of gastrointestinal conditions |
| 05/11/2005 | EP1417172A4 Process for the preparation of amorphous form of torsemide |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1161153B1 Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 05/11/2005 | EP1140124B1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 05/11/2005 | EP1076563B1 Dipeptide caspase inhibitors and the use thereof |
| 05/11/2005 | CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615308A Prucalopride-N-oxide |
| 05/11/2005 | CN1615149A Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/11/2005 | CN1615148A Methods and compositions for derepression of IAP-inhibited caspase |
| 05/11/2005 | CN1615146A 生姜提取物制剂 Ginger extract preparation |
| 05/11/2005 | CN1615140A Polynucleotide therapy |
| 05/11/2005 | CN1613485A Iron-sheet dendrobe compound drop pellets and their preparation |
| 05/11/2005 | CN1613476A Chinese medicine for treating liver diseases |
| 05/11/2005 | CN1613475A Chinese medicine for treating liver diseases |
| 05/11/2005 | CN1613472A Chinese medicine for treating enteritis |
| 05/11/2005 | CN1613465A Oral liquid for hlepatitis B |
| 05/11/2005 | CN1613459A Ginger and goldthread root tablets for diarrhea |
| 05/11/2005 | CN1613457A Yinping yangmi pills |
| 05/11/2005 | CN1613455A Targeting microorgan micro-capsules and their preparation |
| 05/11/2005 | CN1613448A Oral disintegrated and/or oral soluble solid hydrocyclo-benzenenonate |
| 05/11/2005 | CN1613446A Sustained released malotilate preparation for hepa titis and cirrhosis |
| 05/11/2005 | CN1613445A Luteolin, its derivative and use for inhibiting enterocinesia |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200736C Remidies for hepatitis |
| 05/11/2005 | CN1200732C Hepatitis B vaccine with lactic acid-ethanediol copolymer as adjuvant |
| 05/11/2005 | CN1200726C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/11/2005 | CN1200723C White peony and licorice extract and its prepn process |
| 05/11/2005 | CN1200715C Adetphos sodium chloride injection and its preparation method |
| 05/11/2005 | CN1200713C New (aminopropyl) methylphosphinic acids |
| 05/11/2005 | CN1200712C Combination comprising camptothecin and stilbene derivative for treatment of cancer |
| 05/11/2005 | CN1200706C Compositions and methods for treating or preventing inflammatory diseases |